![Noam Shani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Noam Shani served as the Chief Executive Officer at KAHR Medical Ltd. and as Vice President of Research and Development at both Compugen Ltd. and Aevi Genomic Medicine, Inc. Shani holds a graduate and doctorate degree from the Weizmann Institute of Science.
| Companies | Position | End |
|---|---|---|
| COMPUGEN LTD. | Chief Tech/Sci/R&D Officer | - |
| AEVI GENOMIC MEDICINE, INC. | Chief Tech/Sci/R&D Officer | - |
KAHR Medical Ltd.
 KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 4 |
|---|---|
Compugen Ltd.
 Compugen Ltd. BiotechnologyHealth Technology Discovers and researches drug & diagnostics | Health Technology |
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of treatments for auto-immune pediatric disease | Health Technology |
Weizmann Institute of Science
 Weizmann Institute of Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology Develops immunotherapeutic drugs | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
